![]() |
“Every year, nearly 5,000 British
Columbians are diagnosed with blood cancer such as multiple myeloma or leukemia
or thrombosis, which can cause dangerous blood clots,” said Abbott. “Our
support of the Hematology Clinical Trials Unit at
“When you’re suddenly faced with a diagnosis of blood cancer, you
desperately want to hear that there is hope and that a treatment is available,”
said Sindi Hawkins, MLA for Kelowna-Mission. “I am so proud of the Province’s
support of the unit, and our commitment to provide patients with the newest,
best treatments available anywhere in the world.”
The Hematology Clinical Trials Unit was formed in 2004 from private donations. The unit evaluates new treatments for blood cancers, new approaches to stem cell transplantation and new supportive care measures, such as treatment of common infections and therapies that hasten recovery after transplantation. To date, the unit has conducted 39 clinical trials of new drugs, and treated over 300 patients. In a series of trials, 27 patients were treated for chronic myeloid leukemia using a pill instead of undergoing a bone marrow transplant. In another, 169 patients were treated for multiple myeloma, testing alternatives to intravenous chemotherapy.
“Our Hematology Clinical Trials Unit provides patients access to new groundbreaking medications that are less toxic. It is our hope that patients can be treated with a pill and are able to stay at home instead of needing to travel and be admitted to a hospital,” said Dr. Clayton A. Smith, director of the Leukemia and Bone Marrow Transplant Program of B.C. “We are grateful to the provincial government for their support of this innovative unit to help save lives and provide a better quality of life for thousands of patients across B.C.”
“With comprehensive expertise in all facets of hematology, including thrombosis, we are well positioned to be the leading Canadian centre for research,” said Dr. Michael Barnett, head of the VGH and UBC Divisions of Hematology. “Ongoing contributions will help to bolster our drive for ‘made-in-B.C.’ cures for blood diseases.”
“This unique research unit will help ensure British Columbians with blood diseases have access to the latest life-extending drugs,” said Anne Sutherland Boal, chief operating officer of Vancouver Acute. “We thank our partners in the provincial government and VGH & UBC Hospital Foundation. This pivotal funding will allow us to develop our own treatments at VGH and provide better health outcomes for the patients we serve.”
“This is a tremendous example of government and private
donors from the community together setting an example of leadership for others
to follow,” said
As blood
cancer patients require significant amounts of blood products over the course
of their treatments, the public is requested to consider becoming a blood
donor. To make an appointment to donate, please contact Canadian Blood Services
at 1-888-2-DONATE (1-888-236-6283). For more information or to find the nearest
blood donor clinic, visit www.blood.ca.
-30-
|
Contact: |
Michelle Stewart Communications Director Ministry of Health Services 250 812-5571 (cell) 250 952-1887 (media line) |
Director, Marketing & Communications 604 875-5196 |
|
|
||
|
For more information on government services or to subscribe to the Province’s news feeds using RSS, visit the Province’s website at www.gov.bc.ca. |
||